Ovarian, Fallopian Tube and Primary Peritoneal Cancers

Cancer Type	Protocol Title	ClinicalTrials.Gov Link	Eligibility Criteria	Study Contact
Ovarian, Fallopian Tube, Primary Peritoneal	Phase 1 Study of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers	NCT03054298	Am I eligible for this trial?	Carebox
Ovarian, Fallopian Tube, Primary Peritoneal	MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	NCT03585764	Am I eligible for this trial?	Tina Matlawski
Ovarian	A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing Cancer	NCT03907852	Am I eligible for this trial?	Katie Elkins
Ovarian	Phase 1 Trial of Human Chimeric Antigen Receptor Modified T Cells (huCART-meso) Administered in Combination with VCN-01 in Patients With Pancreatic and Serous Epithelial Ovarian Cancer	NCT05057715	Am I eligible for this trial?	Carebox
Recurrent Ovarian	A Phase 1 Study of SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR, in Subjects with Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, or Mesothelioma	NCT05568680	Am I eligible for this trial?	Katie Elkins